Application of machine learning to blood-based biomarkers of Alzheimer's disease in Down syndrome.

Saved in:
Bibliographic Details
Title: Application of machine learning to blood-based biomarkers of Alzheimer's disease in Down syndrome.
Authors: Luckett PH; Division of Neurotechnology Department of Neurological Surgery Washington University School of Medicine St. Louis Missouri USA., Petersen M; Department of Family Medicine Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA., O'Bryant S; Department of Pharmacology & Neuroscience Institute for Translational Research University of North Texas Health Science Center Fort Worth Texas USA., Mapstone M; Department of Neurology University of California Irvine Irvine California USA., Christian BT; Waisman Center University of Wisconsin-Madison Madison Wisconsin USA., Handen B; Department of Psychiatry University of Pittsburgh Pittsburgh Pennsylvania USA., Head E; Department of Pathology & Laboratory Medicine, and Neurology School of Medicine University of California Irvine Irvine California USA., Ances BM; Department of Neurology Washington University School of Medicine St. Louis Missouri USA.
Corporate Authors: Alzheimer's Biomarker Consortium‐Down Syndrome
Source: Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2026 Apr 06; Vol. 18 (2), pp. e70325. Date of Electronic Publication: 2026 Apr 06 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wiley on behalf of the Alzheimer's Association Country of Publication: United States NLM ID: 101654604 Publication Model: eCollection Cited Medium: Print ISSN: 2352-8729 (Print) Linking ISSN: 23528729 NLM ISO Abbreviation: Alzheimers Dement (Amst) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2352-8729
DOI:10.1002/dad2.70325